Self-Assembling Vascular Networks from Pluripotent Stem Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current approaches for differentiating human pluripotent stem cells (hPSCs) into vascular lineage cells face challenges in recreating functional microvasculature, as they often require specific differentiation-inducible feeder layers, embryoid body formation, or genetic manipulation, and struggle to distinguish between perivascular cell types due to overlapping marker expressions.
Innovation Solution
A monolayer culture protocol is developed to derive a bipotent population of vascular lineage cells that can self-assemble into functional microvasculature without intermediate sorting, using transforming growth factor β inhibitor SB431542 and high vascular endothelial growth factor concentrations, allowing for the differentiation of endothelial cells and pericytes from a common source, and defining unique phenotypes for each perivascular cell type.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current differentiation approaches using feeder layers, embryoid body formation, or genetic manipulation are used, then vascular lineage cells can be derived, but the process complexity and time required increase significantly
Solution Approach 1:
The patent extracts and eliminates the unnecessary intermediate steps (feeder layers, embryoid body formation, genetic manipulation) from the differentiation process. By directly differentiating hPSCs into vascular lineage cells through optimized culture conditions with specific growth factors and inhibitors, the method removes complex procedural elements while maintaining derivation reliability.
Solution Approach 2:
The patent performs preliminary optimization of culture conditions including specific growth factor concentrations, inhibitor additions, and matrix coating preparations before initiating differentiation. This preliminary setup ensures that the differentiation process proceeds efficiently without requiring complex intermediate manipulations during the actual differentiation phase.
2Reliability
If current differentiation approaches are used, then vascular cells can be obtained, but the ability to distinguish between perivascular cell types is compromised due to overlapping marker expressions
Solution Approach 1:
The patent applies local quality by establishing distinct phenotypic characteristics for different perivascular cell types (pericytes, vascular smooth muscle cells, adventitial fibroblasts) through controlled differentiation conditions. Each cell type develops specific marker expression patterns and functional properties that enable precise identification and differentiation, resolving the overlapping marker issue through localized phenotypic specialization.
3Reliability
If feeder layers or genetic manipulation are used for vascular differentiation, then cell derivation is achieved, but the clinical applicability and patient-specific customization are reduced
Solution Approach 1:
The patent creates a universal differentiation protocol that can be applied to any hPSC source (embryonic or induced) without requiring cell-type-specific feeder layers or genetic manipulation. This universal approach maintains derivation reliability while enabling patient-specific customization, as the same protocol works across different hPSC sources and can be tailored to individual patient needs for regenerative medicine applications.
Data Source
Figure 1A~1D
Figure 1E~1G
Figure 1H~2A
AI summary
The present invention is in the area of pluripotent stem cells and more particularly deals with a method to differentiate a vascular network from stem cells.